Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steve Rees

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Future Medicinal Chemistry|October 1, 2015
The promise of open innovation in drug discovery: an industry perspectiveSteve Rees
Nature Reviews. Drug Discovery|November 21, 2015
Towards a hit for every targetSteve Rees, Philip Gribbon, Karen Birmingham, et al.
Journal of Biomolecular Screening|December 25, 2012
The BlueScreen-384 assay as an indicator of genotoxic hazard potential in early-stage drug discoveryKate Simpson, Nicola Bevan, Paul Hastwell, et al.
BMJ Open|September 4, 2020
Intensive Care Weaning (iCareWean) protocol on weaning from mechanical ventilation: a single-blinded multicentre randomised control trial comparing an open-loop decision support system and routine care, in the general intensive care unitM P Vizcaychipi, Laura Martins, James R White, et al.
Frontiers in Pharmacology|May 13, 2022
A Combined Human <i>in Silico</i> and CRISPR/Cas9-Mediated <i>in Vivo</i> Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target ValidationMatthew J Winter, Yosuke Ono, Jonathan S Ball, et al.
Nature Reviews. Drug Discovery|January 20, 2018
Impact of a five-dimensional framework on R&D productivity at AstraZenecaPaul Morgan, Dean G Brown, Simon Lennard, et al.
Journal of Biomolecular Screening|February 12, 2013
Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptorsCraig Southern, Jennifer M Cook, Zaynab Neetoo-Isseljee, et al.
Scientific Reports|February 22, 2022
Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testingOona Delpuech, Julie A Douthwaite, Thomas Hill, et al.
Nature Communications|August 14, 2023
Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editingSandra Wimberger, Nina Akrap, Mike Firth, et al.
Scientific Reports|February 25, 2022
Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facilityJulie A Douthwaite, Christopher A Brown, John R Ferdinand, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Future Medicinal Chemistry|October 1, 2015
The promise of open innovation in drug discovery: an industry perspectiveSteve Rees
Nature Reviews. Drug Discovery|November 21, 2015
Towards a hit for every targetSteve Rees, Philip Gribbon, Karen Birmingham, et al.
Journal of Biomolecular Screening|December 25, 2012
The BlueScreen-384 assay as an indicator of genotoxic hazard potential in early-stage drug discoveryKate Simpson, Nicola Bevan, Paul Hastwell, et al.
BMJ Open|September 4, 2020
Intensive Care Weaning (iCareWean) protocol on weaning from mechanical ventilation: a single-blinded multicentre randomised control trial comparing an open-loop decision support system and routine care, in the general intensive care unitM P Vizcaychipi, Laura Martins, James R White, et al.
Frontiers in Pharmacology|May 13, 2022
A Combined Human <i>in Silico</i> and CRISPR/Cas9-Mediated <i>in Vivo</i> Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target ValidationMatthew J Winter, Yosuke Ono, Jonathan S Ball, et al.
Nature Reviews. Drug Discovery|January 20, 2018
Impact of a five-dimensional framework on R&D productivity at AstraZenecaPaul Morgan, Dean G Brown, Simon Lennard, et al.
Journal of Biomolecular Screening|February 12, 2013
Screening β-arrestin recruitment for the identification of natural ligands for orphan G-protein-coupled receptorsCraig Southern, Jennifer M Cook, Zaynab Neetoo-Isseljee, et al.
Scientific Reports|February 22, 2022
Heat inactivation of clinical COVID-19 samples on an industrial scale for low risk and efficient high-throughput qRT-PCR diagnostic testingOona Delpuech, Julie A Douthwaite, Thomas Hill, et al.
Nature Communications|August 14, 2023
Simultaneous inhibition of DNA-PK and Polϴ improves integration efficiency and precision of genome editingSandra Wimberger, Nina Akrap, Mike Firth, et al.
Scientific Reports|February 25, 2022
Improving the efficiency and effectiveness of an industrial SARS-CoV-2 diagnostic facilityJulie A Douthwaite, Christopher A Brown, John R Ferdinand, et al.
Pageof 1